<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03621280</url>
  </required_header>
  <id_info>
    <org_study_id>COR-2017-OLE</org_study_id>
    <nct_id>NCT03621280</nct_id>
  </id_info>
  <brief_title>Open-label Treatment in Cushing's Syndrome</brief_title>
  <acronym>OPTICS</acronym>
  <official_title>An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cortendo AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cortendo AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a long-term, open-label extension study of levoketoconazole in subjects with
      endogenous Cushing's Syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a long-term, OLE study of levoketoconazole in subjects with endogenous CS who have
      completed one or both parent studies or otherwise potentially qualify for this study, as
      defined in the eligibility criteria.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 7, 2019</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Open-Label Extension Study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes from Baseline in 24-h UFC</measure>
    <time_frame>From Baseline to final study visit or up to a maximum of 3 years, whichever comes first.</time_frame>
    <description>Changes or shifts from baseline in mUFC</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes from Baseline in Late Night Salivary Cortisol</measure>
    <time_frame>From Baseline to final study visit or up to a maximum of 3 years, whichever comes first.</time_frame>
    <description>Changes or shifts from baseline in late night salivary cortisol levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes from Baseline in AEs/SAEs/AESI as assessed by CTCAE V4.03</measure>
    <time_frame>From Baseline to final study visit or up to a maximum of 3 years, whichever comes first.</time_frame>
    <description>Changes from Baseline in the incidence and severity of AEs, SAEs, AESIs</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cushing Syndrome</condition>
  <condition>Cushing Disease</condition>
  <arm_group>
    <arm_group_label>Levoketoconazole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Levoketoconazole taken twice daily up to 1200 mg daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levoketoconazole</intervention_name>
    <description>Levoketoconazole up to 1200 mg daily</description>
    <arm_group_label>Levoketoconazole</arm_group_label>
    <other_name>COR-003</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Completed the Extended Evaluation Phase of Study COR-2012-01 (i.e. M12)

          2. Completed the Restoration Phase of Study COR-2017-01 (i.e. RES2)

             NOTE: Subjects meeting criteria 1 or 2 above who have had a break in therapy may be
             eligible only after discussion with the Medical Monitor. If eligible, such subjects
             should resume levoketoconazole at or below the prior therapeutic dose at the
             discretion of the Investigator. Prior to resuming treatment with levoketoconazole,
             other therapies for Cushing's Syndrome must undergo an appropriate washout period,
             with minimum durations as follows:

               -  Ketoconazole or metyrapone: 2 weeks;

               -  Dopamine agonists: bromocriptine (2 weeks), cabergoline (8 weeks);

               -  Octreotide acetate LAR, lanreotide Autogel, pasireotide LAR: 12 weeks;

               -  Lanreotide SR: 8 weeks;

               -  Octreotide acetate (immediate release) or short-acting pasireotide: 1 week;

               -  Mifepristone (RU 486, KORLYM): 4 weeks;

               -  Megestrol acetate or medroxyprogesterone acetate (and selected other synthetic
                  progestins): 6 weeks.

          3. Currently in a named patient program or other Expanded Access Program receiving
             levoketoconazole

          4. Were levoketoconazole-naïve prior to entry and received early rescue therapy with
             open-label levoketoconazole in Study COR-2017-01.

          5. Were levoketoconazole-naïve prior to entry and were enrolled in Study COR-2017-01 in
             the Dose Titration and Maintenance Phase when randomization was closed. (NOTE: Such
             subjects may continue in Study COR-2017-01 until a therapeutic dose has been
             established or until the end of the Dose Titration and Maintenance Phase, whichever
             comes first).

        Exclusion Criteria:

          1. Discontinued levoketoconazole while participating in Study COR-2012-01 or Study
             COR-2017-01 or a named patient program or other Expanded Access program, due to safety
             or tolerability concerns or lack of efficacy.

          2. Scheduled for surgery for treatment of CS or received surgery for treatment of CS
             within the 6 weeks prior to Screening.

          3. Treated with mitotane within 6 months prior to enrollment.

          4. History of malignancy, including adrenal or pituitary carcinomas (other than low-risk,
             well-differentiated carcinomas of thyroid, breast or prostate that are very unlikely
             to require further treatment in the opinion of the treating physician, or squamous
             cell or basal cell carcinoma of the skin).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xavier Valencia, MD</last_name>
    <role>Study Director</role>
    <affiliation>Cortendo AB</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cortendo AB</last_name>
    <phone>610-254-9200</phone>
    <email>OPTICS@cortendo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cortendo AB Study Contact</last_name>
    <phone>610-254-9200</phone>
    <email>OPTICS@cortendo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Southern California Internal Medicine - Keck Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Monica Chiu</last_name>
      <phone>323-865-1225</phone>
      <email>monica.chiu@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>John Carmichael, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Ning-Ai Liu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCLA School of Medicine</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Asmaa Dabbagh, MD</last_name>
      <phone>310-825-5874</phone>
      <email>adabbagh@mednet.ucla.edu</email>
    </contact>
    <investigator>
      <last_name>Anthony Heany, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Center for Diabetes and Endocrine Care</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33312</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sam Lerman, MD</last_name>
      <phone>954-963-7191</phone>
      <email>slerman@diabetes-endocare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emilee Wehunt</last_name>
      <phone>404-779-3746</phone>
      <email>emorga9@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Adriana Ioachimescu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daphne Adelman</last_name>
      <phone>312-908-9002</phone>
      <email>d-adelman@northwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Mark Molitch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan Internal Medicine - MEND</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elizabeth Wu</last_name>
      <phone>734-764-4048</phone>
      <email>elizwu@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Tobias Else, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Traci Bell</last_name>
      <phone>314-747-5371</phone>
      <email>traci.bell@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Julie Silverstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of New Mexico HSC - HSC Sponsored Projects Office</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Greg Trejo</last_name>
      <phone>617-726-7473</phone>
      <email>GTrejo@salud.unm.edu</email>
    </contact>
    <investigator>
      <last_name>Patricia Kapsner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hannah Robins</last_name>
      <phone>646-888-1365</phone>
      <email>robinsh@mskcc.org</email>
    </contact>
    <investigator>
      <last_name>Eliza Geer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Williams</last_name>
      <phone>503-494-9546</phone>
      <email>nelsjess@ohsu.edu</email>
    </contact>
    <investigator>
      <last_name>Maria Fleseriu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sveti Georgy University Hospital Clinic of Endocrinology and Metabolic Diseases</name>
      <address>
        <city>Plovdiv</city>
        <zip>4000</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Miteva</last_name>
      <phone>+35932602486</phone>
      <email>m_miteva@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Maria Orbetzova, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alexandovska University Hospital</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deniz Bakalov, MD</last_name>
      <phone>+359887726683</phone>
      <email>dbakalov@abv.bg</email>
    </contact>
    <investigator>
      <last_name>Zdravko Kamenov</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Specialized Hospital for Active Treatment in Endocrinology</name>
      <address>
        <city>Sofia</city>
        <zip>1431</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Atanaska Elenkova</last_name>
      <phone>+359888719801</phone>
      <email>atanaskae@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Sabrina Zaharieva</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>APHM Hôpital de la Conception</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mona Sahnoun</last_name>
      <phone>+33491383375</phone>
      <email>mouna.sahnoun@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Thierry Brue</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital of Athens Evangelismos Department of Endocrinology and Diabete</name>
      <address>
        <city>Athens</city>
        <zip>10676</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dimitra Vassiliadi</last_name>
      <phone>+302132041825</phone>
      <email>dimitravas@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Stylianos Tsagarakis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital of Athens 'G. Gennimatas' Department of Endocrinology-Diabetes Centre</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Athina Markou</last_name>
      <phone>+302107779146</phone>
      <email>amarkouuk@yahoo.co.uk</email>
    </contact>
    <investigator>
      <last_name>Theodora Kounadi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital of Athens 'Laiko'</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marina Tsoli</last_name>
      <phone>+306972692962</phone>
      <email>martso.mt@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Gregory Kaltsas</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University General Hospital of Ioannina Department of Endocrinology</name>
      <address>
        <city>Ioánnina</city>
        <zip>45500</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Christou</last_name>
      <phone>+302651099734</phone>
      <email>mariachristou1@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Stilianos Tigas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hippokration General Hospital Endocrinology and Diabetes Department</name>
      <address>
        <city>Thessaloníki</city>
        <zip>54642</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paraskevi Komzia</last_name>
      <phone>+306932311009</phone>
      <email>Voulak2008@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Fotini Adamidou, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Semmelweis Egyetem II. Belgyógyászati Klinika</name>
      <address>
        <city>Budapest</city>
        <zip>1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judit Toke, MD</last_name>
      <phone>+36-20-663-2908</phone>
      <email>tokejudit@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Miklos Toth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bnai Zion Medical Center Endocrinology Institute</name>
      <address>
        <city>Haifa</city>
        <zip>34802</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michal Yeiches</last_name>
      <phone>+972-5-282-830-62</phone>
      <email>yeiches@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Leonard Saiegh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rabin Medical Center, Beilinson Campus</name>
      <address>
        <city>Petah tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liat Rot</last_name>
      <phone>+972-3-921 1403</phone>
      <email>liatro3@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Ilan Shimon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tel Aviv-Sourasky Medical Center Institute Endocrinology Metabolism &amp; Hypertension</name>
      <address>
        <city>Tel Aviv</city>
        <zip>6423906</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miri Margaliot</last_name>
      <phone>+972-3-697 4243</phone>
      <email>mirim@tlvmc.gov.il</email>
    </contact>
    <investigator>
      <last_name>Yona Greenman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinica Endocrinologia malattie del Metabolismo</name>
      <address>
        <city>Ancona</city>
        <zip>60126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Giorgio Arnaldi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Genova</name>
      <address>
        <city>Genova</city>
        <zip>16132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Fredeico Gatto</last_name>
      <phone>+39 010 353 8886</phone>
      <email>fedgatto@hotmail.it</email>
    </contact>
    <investigator>
      <last_name>Diego Ferone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AOU Policlinico G. Martino Sezione di Endocrinologia</name>
      <address>
        <city>Messina</city>
        <zip>98125</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Luisa Tindara Torre</last_name>
      <phone>+39 90 2213945</phone>
      <email>marialuisatorre78@libero.it</email>
    </contact>
    <investigator>
      <last_name>Salvatore Cannavo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Via Sergio Pansini 5 Uni Naples FedericoII Dept of Molecular&amp;Clinical Endocrinology&amp;Oncology</name>
      <address>
        <city>Naples</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Monica De Leo</last_name>
      <phone>+393488583899</phone>
      <email>monicadeleo25@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Rosario Pivonello</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico Universitario Sant'Andrea</name>
      <address>
        <city>Roma</city>
        <zip>00189</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Antonio Stigliano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico Agostino Gemelli Università Cattolica del Sacro Cuore Endocrinology</name>
      <address>
        <city>Rome</city>
        <zip>168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pietro Locantore</last_name>
      <phone>+(39) 328 828 2256</phone>
      <email>pietro.locantore@icloud.com</email>
    </contact>
    <investigator>
      <last_name>Alfredo Pontecorvi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Turin</name>
      <address>
        <city>Turin</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Silvia Grottoli</last_name>
      <phone>+39(0)0116335544</phone>
      <email>silvia.grottoli@unito.it</email>
    </contact>
    <investigator>
      <last_name>Roberta Giordano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Leiden University Medical Center</name>
      <address>
        <city>Leiden</city>
        <zip>2333 ZA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sabrina Hendriksen</last_name>
      <phone>+31715263082</phone>
      <email>s.hendriksen@lumc.nl</email>
    </contact>
    <investigator>
      <last_name>Nienke Biermasz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015 CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sjaan Poldermans</last_name>
      <phone>+31(0) 107031598</phone>
      <email>b.poldermans@erasmusmc.nl</email>
    </contact>
    <investigator>
      <last_name>Richard Feelders, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maria Sklodowska-Curie Memorial Institute</name>
      <address>
        <city>Gliwice</city>
        <zip>44-101</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jolanta Krajewska</last_name>
      <phone>+48 322789301</phone>
      <email>jolanta.krajewska@io.gliwice.pl</email>
    </contact>
    <investigator>
      <last_name>Barbara Jarzab</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instytut Centrum Zdrowia Matki Polki</name>
      <address>
        <city>Łódź</city>
        <zip>93-338</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magdalena Stasiak</last_name>
      <phone>+48502049292</phone>
      <email>mstasiak33@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Andrzej Lewinski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institutul National de Endocrinologie C.I. Parhon</name>
      <address>
        <city>Cluj-Napoca</city>
        <zip>400349</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Monica Gheorghiu</last_name>
      <phone>+40722524002</phone>
      <email>monicagheorghiu@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Corin V Badiu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean de Urgenta Cluj-Napoca</name>
      <address>
        <city>Cluj-Napoca</city>
        <zip>400349</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alina Silaghi</last_name>
      <email>alinasilaghi@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Carmen Emanuela Georgescu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean de Urgenta &quot;Pius Brinzeu&quot;</name>
      <address>
        <city>Timişoara</city>
        <zip>300723</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Daniela Amzar</last_name>
      <phone>+40744690639</phone>
      <email>dana_amzar@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Melania-Olga Balas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic Judetean Mures</name>
      <address>
        <city>Târgu-Mureş</city>
        <zip>540139</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adelina Micheu</last_name>
      <email>adelina_micheu@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Maria Ionela Pascanu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universidad De La Ribera</name>
      <address>
        <city>Alzira</city>
        <zip>46600</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Angeles Martorell</last_name>
      <phone>+34962458580</phone>
      <email>mamartorell@hospital-ribera.com</email>
    </contact>
    <investigator>
      <last_name>Carmen Fajardo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elena Fernandez Duran</last_name>
      <phone>+34913368056</phone>
      <email>elena.fernandezd@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>Manuel Luque Ramirez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Bulgaria</country>
    <country>France</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Denmark</country>
    <country>Turkey</country>
  </removed_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>May 18, 2018</study_first_submitted>
  <study_first_submitted_qc>August 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 8, 2018</study_first_posted>
  <last_update_submitted>October 7, 2019</last_update_submitted>
  <last_update_submitted_qc>October 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>ACTH-Secreting Pituitary Adenoma</mesh_term>
    <mesh_term>Pituitary ACTH Hypersecretion</mesh_term>
    <mesh_term>Cushing Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

